• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌钙蛋白C(TNNC1)作为常染色体隐性遗传限制性心肌病的致病基因,可导致婴儿期致命结局的证据。

Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy.

作者信息

Ploski Rafal, Rydzanicz Malgorzata, Ksiazczyk Tomasz M, Franaszczyk Maria, Pollak Agnieszka, Kosinska Joanna, Michalak Ewa, Stawinski Piotr, Ziolkowska Lidia, Bilinska Zofia T, Werner Bozena

机构信息

Department of Medical Genetics, Centre of Biostructure, Medical University of Warsaw, Warsaw, Poland.

Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, Warsaw, Poland.

出版信息

Am J Med Genet A. 2016 Dec;170(12):3241-3248. doi: 10.1002/ajmg.a.37860. Epub 2016 Sep 8.

DOI:10.1002/ajmg.a.37860
PMID:27604170
Abstract

Restrictive cardiomyopathy is a rare form of pediatric cardiac disease, for which the known genes include MYH7, TNNT2, TNNI3, ACTC1, and DES. We describe a pediatric proband with fatal restrictive cardiomyopathy associated with septal hypertrophy and compound heterozygosity for TNNC1 mutations (NM_003280: p.A8V [c.C23T] and p.D145E [c.C435A]). This association between restrictive cardiomyopathy and TNNC1 mutations was strengthened by prospective observations on the second pregnancy in the family which revealed, in the presence of the same TNNC1 genotype, prenatally diagnosed hypertrophic cardiomyopathy which evolved into restrictive cardiomyopathy, heart failure and death at the age of 9 months. Contrary to previous reports, family and population analyses showed that each of the TNNC1 variants was not pathogenic when present alone. Our results (i) confirm that genetic backgrounds of hypertrophic cardiomyopathy and restrictive cardiomyopathy overlap and (ii) indicate that TNNC1 is a likely novel gene for autosomal recessive restrictive cardiomyopathy. © 2016 Wiley Periodicals, Inc.

摘要

限制型心肌病是一种罕见的儿科心脏疾病,已知与之相关的基因包括MYH7、TNNT2、TNNI3、ACTC1和DES。我们描述了一名患有致命性限制型心肌病的儿科先证者,该疾病伴有室间隔肥厚以及TNNC1突变(NM_003280:p.A8V [c.C23T] 和p.D145E [c.C435A])的复合杂合性。通过对该家族第二次妊娠的前瞻性观察,加强了限制型心肌病与TNNC1突变之间的这种关联,观察结果显示,在相同的TNNC1基因型存在的情况下,产前诊断为肥厚型心肌病,在9个月大时发展为限制型心肌病、心力衰竭并死亡。与之前的报道相反,家族和群体分析表明,每个TNNC1变体单独存在时都不具有致病性。我们的结果(i)证实肥厚型心肌病和限制型心肌病的遗传背景存在重叠,(ii)表明TNNC1可能是常染色体隐性限制型心肌病的一个新基因。© 2016威利期刊公司

相似文献

1
Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy.肌钙蛋白C(TNNC1)作为常染色体隐性遗传限制性心肌病的致病基因,可导致婴儿期致命结局的证据。
Am J Med Genet A. 2016 Dec;170(12):3241-3248. doi: 10.1002/ajmg.a.37860. Epub 2016 Sep 8.
2
In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.肌钙蛋白C基因敲入(A8V)小鼠的体内分析:TNNC1是肥厚型心肌病易感基因的证据
Circ Cardiovasc Genet. 2015 Oct;8(5):653-664. doi: 10.1161/CIRCGENETICS.114.000957. Epub 2015 Aug 24.
3
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.TNNC1编码的肌钙蛋白C中新型肥厚型心肌病易感性突变的分子与功能特征
J Mol Cell Cardiol. 2008 Aug;45(2):281-8. doi: 10.1016/j.yjmcc.2008.05.003. Epub 2008 May 11.
4
A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.TNNC1 编码的心肌肌钙蛋白 C 中的突变,即 TNNC1-A31S,可导致肥厚型心肌病和心室颤动。
J Biol Chem. 2012 Sep 14;287(38):31845-55. doi: 10.1074/jbc.M112.377713. Epub 2012 Jul 18.
5
Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.肌钙蛋白基因中心肌病相关变异的荟萃分析确定了与更差临床结局相关的基因座和基因内热点。
J Mol Cell Cardiol. 2020 May;142:118-125. doi: 10.1016/j.yjmcc.2020.04.005. Epub 2020 Apr 9.
6
A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3).一例由心肌肌钙蛋白I(TNNI3)新突变引起的隐性限制型心肌病病例报告。
BMC Med Genet. 2019 Apr 5;20(1):61. doi: 10.1186/s12881-019-0793-z.
7
[Analysis of cardiac troponin C gene TNNC1 c. G175C mutation in a Chinese pedigree with familial hypertrophic cardiomyopathy and the correlation between genotype and phenotype].[中国一个家族性肥厚型心肌病家系中心肌肌钙蛋白C基因TNNC1 c.G175C突变分析及基因型与表型的相关性]
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Dec 24;44(12):1020-1023. doi: 10.3760/cma.j.issn.0253-3758.2016.12.006.
8
Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death.肌钙蛋白C(TNNC1)中的新型移码突变与肥厚型心肌病和猝死相关。
Cardiol Young. 2011 Jun;21(3):345-8. doi: 10.1017/S1047951110001927. Epub 2011 Jan 25.
9
Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.通过下一代测序检测的肌球蛋白结合蛋白C(MYBPC3)基因突变所致限制性心肌病的新型表型-基因型相关性
J Am Heart Assoc. 2015 Jul 10;4(7):e001879. doi: 10.1161/JAHA.115.001879.
10
Deletion in TNNI3 gene is associated with restrictive cardiomyopathy.TNNI3基因缺失与限制性心肌病相关。
Int J Cardiol. 2009 Jan 24;131(3):410-2. doi: 10.1016/j.ijcard.2007.07.108. Epub 2007 Nov 14.

引用本文的文献

1
Induced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy.诱导多能干细胞在心肌病中的应用:推动疾病建模、治疗开发和再生治疗
Int J Mol Sci. 2025 May 22;26(11):4984. doi: 10.3390/ijms26114984.
2
Investigating the dual role of mitochondrial and nuclear genome variants in pediatric cardiomyopathies.探究线粒体和核基因组变异在小儿心肌病中的双重作用。
Sci Rep. 2025 May 14;15(1):16678. doi: 10.1038/s41598-025-01007-0.
3
Cardiomyopathy: pathogenesis and therapeutic interventions.
心肌病:发病机制与治疗干预措施
MedComm (2020). 2024 Oct 25;5(11):e772. doi: 10.1002/mco2.772. eCollection 2024 Nov.
4
Genotype-Phenotype Associations with Restrictive Cardiomyopathy Induced by Pathogenic Genetic Mutations.致病性基因突变所致限制性心肌病的基因型-表型关联
Rev Cardiovasc Med. 2022 May 25;23(6):185. doi: 10.31083/j.rcm2306185. eCollection 2022 Jun.
5
Challenging of ECMO application in pediatric restrictive cardiomyopathy: case report of a novel variant.体外膜肺氧合在小儿限制性心肌病中的应用挑战:一例新型变异病例报告
Front Cardiovasc Med. 2024 May 24;11:1365209. doi: 10.3389/fcvm.2024.1365209. eCollection 2024.
6
A variant in a five-generation-family with hypertrophic cardiomyopathy.一个患有肥厚型心肌病的五代家族中的一种变异。
Front Genet. 2024 Feb 8;15:1306333. doi: 10.3389/fgene.2024.1306333. eCollection 2024.
7
Focus on Paediatric Restrictive Cardiomyopathy: Frequently Asked Questions.关注小儿限制性心肌病:常见问题解答。
Diagnostics (Basel). 2023 Dec 14;13(24):3666. doi: 10.3390/diagnostics13243666.
8
Double Heterozygous Pathogenic Variants in the and Genes in a 5-Year-Old Patient with Thoracic Aortic Aneurysm and Polycystic Kidney Disease.5 岁患儿同时患有胸主动脉瘤和多囊肾病,携带 和 基因的双杂合致病性变异。
Genes (Basel). 2023 Oct 24;14(11):1983. doi: 10.3390/genes14111983.
9
The Role of Genetics in the Management of Heart Failure Patients.遗传学在心力衰竭患者管理中的作用。
Int J Mol Sci. 2023 Oct 16;24(20):15221. doi: 10.3390/ijms242015221.
10
Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C.肌钙蛋白 C 突变所致心肌病的小鼠模型。
Int J Mol Sci. 2023 Aug 2;24(15):12349. doi: 10.3390/ijms241512349.